Literature DB >> 18755231

Attenuation of abnormal glutamate release in zinc deficiency by zinc and Yokukansan.

Atsushi Takeda1, Haruna Tamano, Hiromasa Itoh, Naoto Oku.   

Abstract

The mechanism of the abnormal increase in extracellular glutamate concentration in the hippocampus induced with 100mM KCl in zinc deficiency is unknown. In the present study, the changes in glutamate release (exocytosis) and GLT-1, a glial glutamate transporter, expression were studied in young rats fed a zinc-deficient diet for 4 weeks. Exocytosis at mossy fiber boutons was enhanced as reported previously and GLT-1 protein was increased in the hippocampus. The enhanced exocytosis is thought to increase extracellular glutamate concentration. However, the basal concentration of extracellular glutamate in the hippocampus was not increased by zinc deficiency, suggesting that GLT-1 protein increased serves to maintain the basal concentration of extracellular glutamate. The enhanced exocytosis was attenuated in the presence of 100microM ZnCl(2), which attenuated the abnormal increase in extracellular glutamate induced with high K(+) in zinc deficiency. The present study indicates that zinc attenuates abnormal glutamate release in zinc deficiency. The enhanced exocytosis was also attenuated in slices from zinc-deficient rats administered Yokukansan, a herbal medicine, in which the abnormal increase in extracellular glutamate induced with high K(+) was attenuated. It is likely that Yokukansan is useful for prevention or cure of abnormal glutamate release. The enhanced exocytosis in zinc deficiency is a possible mechanism on abnormal increase in extracellular glutamate in the hippocampus induced with high K(+).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755231     DOI: 10.1016/j.neuint.2008.07.009

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  15 in total

1.  An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease.

Authors:  Taku Hatano; Nobutaka Hattori; Tadaaki Kawanabe; Yasuo Terayama; Norihiro Suzuki; Yasuo Iwasaki; Toshiki Fujioka
Journal:  J Neural Transm (Vienna)       Date:  2013-10-30       Impact factor: 3.575

2.  Drug discovery from Chinese medicine against neurodegeneration in Alzheimer's and vascular dementia.

Authors:  Yuen-Shan Ho; Kwok-Fai So; Raymond Chuen-Chung Chang
Journal:  Chin Med       Date:  2011-04-22       Impact factor: 5.455

3.  Insight into glutamate excitotoxicity from synaptic zinc homeostasis.

Authors:  Atsushi Takeda
Journal:  Int J Alzheimers Dis       Date:  2010-12-20

4.  Pharmacokinetics of Active Components of Yokukansan, a Traditional Japanese Herbal Medicine after a Single Oral Administration to Healthy Japanese Volunteers: A Cross-Over, Randomized Study.

Authors:  Hiroyuki Kitagawa; Masaya Munekage; Kengo Ichikawa; Ian Fukudome; Eri Munekage; Yuka Takezaki; Takashi Matsumoto; Yasushi Igarashi; Haruo Hanyu; Kazuhiro Hanazaki
Journal:  PLoS One       Date:  2015-07-07       Impact factor: 3.240

Review 5.  Behavioral Abnormality Induced by Enhanced Hypothalamo-Pituitary-Adrenocortical Axis Activity under Dietary Zinc Deficiency and Its Usefulness as a Model.

Authors:  Atsushi Takeda; Haruna Tamano; Ryusuke Nishio; Taku Murakami
Journal:  Int J Mol Sci       Date:  2016-07-16       Impact factor: 5.923

6.  Influences of yokukansankachimpihange on aggressive behavior of zinc-deficient mice and actions of the ingredients on excessive neural exocytosis in the hippocampus of zinc-deficient rats.

Authors:  Haruna Tamano; Enya Yusuke; Kazuki Ide; Atsushi Takeda
Journal:  Exp Anim       Date:  2016-05-30

7.  Yokukansan improves distress of medical staff, and cognitive function and motivation in patients with destructive and aggressive behaviors after traumatic brain injury.

Authors:  Tomomichi Kan'o; Jing-Yan Han; Kuniaki Nakahara; Shingo Konno; Mayuko Shibata; Takao Kitahara; Kazui Soma
Journal:  Acute Med Surg       Date:  2014-03-05

Review 8.  Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions.

Authors:  Hideki Okamoto; Masaomi Iyo; Keigo Ueda; Cheolsun Han; Yoshiro Hirasaki; Takao Namiki
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-12       Impact factor: 2.570

Review 9.  Zinc in the Glutamatergic Theory of Depression.

Authors:  Katarzyna Mlyniec
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

10.  Randomized phase II study of TJ-54 (Yokukansan) for postoperative delirium in gastrointestinal and lung malignancy patients.

Authors:  Nobuhiro Sugano; Toru Aoyama; Tsutomu Sato; Mariko Kamiya; Shinya Amano; Naoto Yamamoto; Takuya Nagashima; Yoshihiro Ishikawa; Katsuhiko Masudo; Masataka Taguri; Takeharu Yamanaka; Yuji Yamamoto; Hiroshi Matsukawa; Ryuji Shiraisi; Takashi Oshima; Norio Yukawa; Yasushi Rino; Munetaka Masuda
Journal:  Mol Clin Oncol       Date:  2017-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.